One year later, Sano et al. [47] studied the effect of mutations in TET2 or DNMT3A in HF, and reported that, in two experimental mouse models of HF, loss of Tet2 in bone marrow cells led to reduced left ventricle ejection fraction and increased cardiac fibrosis and remodeling. Here, TET2 is linked to fibrosis.